{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T18:31:09Z","timestamp":1700418669205},"reference-count":56,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[1998,8,1]],"date-time":"1998-08-01T00:00:00Z","timestamp":901929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T00:00:00Z","timestamp":1578441600000},"content-version":"vor","delay-in-days":7830,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[1998,8]]},"DOI":"10.1023\/a:1008414002612","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T14:30:06Z","timestamp":1040567406000},"page":"797-801","source":"Crossref","is-referenced-by-count":6,"title":["Peripheral T-cell lymphoma: A developing concept"],"prefix":"10.1016","volume":"9","author":[{"given":"S.A.","family":"Piled","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Ascani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Sabattini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Falini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1023\/A:1008414002612_bb0010","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/1097-0142(1984)54:4<687::AID-CNCR2820540416>3.0.CO;2-G","article-title":"Caribbean T-cell lymphoma\/leukemia","volume":"54","author":"Swerdlow","year":"1984","journal-title":"Cancer"},{"key":"10.1023\/A:1008414002612_bb0015","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1136\/jcp.40.9.995","article-title":"Histopathology and immuno-histochemistry of peripheral T-cell lymphomas: A proposal for their classification","volume":"40","author":"Suchi","year":"1987","journal-title":"J Clin Pathol"},{"key":"10.1023\/A:1008414002612_bb0020","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1002\/1097-0142(19880515)61:10<2060::AID-CNCR2820611022>3.0.CO;2-D","article-title":"Characterization of the spectrum of postthymic T-cell malignancies in Taiwan. A clinicopathologic study of HTLV1-positive and HTLV1-negative cases","volume":"61","author":"Su","year":"1988","journal-title":"Cancer"},{"key":"10.1023\/A:1008414002612_bb0025","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/1097-0142(19820515)49:10<2112::AID-CNCR2820491024>3.0.CO;2-2","article-title":"National Cancer Institute sponsored study of classifications of non-Hodgkin\u2019s lymphomas: Summary and description of a Working Formulation for clinical usage","volume":"49","author":"Non-Hodgkin\u2019s lymphoma pathologic classification project","year":"1982","journal-title":"Cancer"},{"key":"10.1023\/A:1008414002612_bb0030","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0140-6736(88)90367-4","article-title":"Updated Kiel Classification for lymphomas","volume":"I","author":"Stansfeld","year":"1988","journal-title":"Lancet"},{"key":"10.1023\/A:1008414002612_bb0035","series-title":"Histopathology of non-Hodgkin\u2019s lymphomas (based on the Updated Kiel Classification)","author":"Lennert","year":"1992"},{"key":"10.1023\/A:1008414002612_bb0040","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1365-2559.1991.tb01451.x","article-title":"Peripheral T-cell lymphomas: An evaluation of reproducibility of the Updated Kiel Classification","volume":"18","author":"Hastrup","year":"1991","journal-title":"Histopathology"},{"key":"10.1023\/A:1008414002612_bb0045","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A Revised European\u2013American Classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"key":"10.1023\/A:1008414002612_bb0050","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","article-title":"A clinical evaluation of the International Lymphoma Study Group Classification of non-Hodgkin\u2019s lymphoma","volume":"89","author":"The non-Hodgkin\u2019s lymphoma classification project","year":"1997","journal-title":"Blood"},{"key":"10.1023\/A:1008414002612_bb0055","series-title":"Classification of neoplastic diseases of the hematopoietic and lymphoid systems. Presenters\u2019 visual aids and handouts. Virginia: Airlie House","first-page":"3","author":"World Health Organization clinical advisory committee meeting","year":"1997"},{"key":"10.1023\/A:1008414002612_bb0060","series-title":"T cell lymphomas: WHO Classification. IX Meeting of the European Association for Haematopathology. April 26\u201329","author":"Muller-Hermelink","year":"1998"},{"key":"10.1023\/A:1008414002612_bb0065","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1023\/A:1008200307625","article-title":"Clinico-pathologic study of 168 cases diagnosed according to the R","volume":"8","author":"Ascani","year":"1997","journal-title":"E.A.L. Classification. Ann Oncol"},{"key":"10.1023\/A:1008414002612_bb0070","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1182\/blood.V89.12.4514","article-title":"Evaluation of the Revised European-American Lymphoma Classification confirms the clinical relevance of immunophenotype in 560 cases of aggressive non-Hodgkin\u2019s lymphoma","volume":"89","author":"Melnyk","year":"1997","journal-title":"Blood"},{"key":"10.1023\/A:1008414002612_bb0075","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1200\/JCO.1997.15.6.2296","article-title":"Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphoma","volume":"15","author":"Ansell","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008414002612_bb0080","first-page":"354","article-title":"EORTC Classification for primary cutaneous lymphomas: A proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer","volume":"90","author":"Willemze","year":"1997","journal-title":"Blood"},{"key":"10.1023\/A:1008414002612_bb0085","doi-asserted-by":"crossref","unstructured":"Campo E, Gaulard P, Zucca E et al. Report of the European Task Force on Lymphomas: Workshop on peripheral T-cell lymphomas. Ann Oncol 9 (8): 835\u201343 (this issue).","DOI":"10.1023\/A:1008439620513"},{"key":"10.1023\/A:1008414002612_bb0090","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Guillermo A, Cid J, Salar A et al. Peripheral T-cell lymphomas: Initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. Classification. Ann Oncol 9 (8): 849\u201355 (this issue).","DOI":"10.1023\/A:1008418727472"},{"key":"10.1023\/A:1008414002612_bb0095","doi-asserted-by":"crossref","unstructured":"Bernengo MG, Quaglino P, Novelli M et al. Prognostic factors in S\u00e9zary syndrome: A multivariate analysis of clinical, haematological and immunological features. Ann Oncol 9 (8): 857\u201363 (this issue).","DOI":"10.1023\/A:1008397323199"},{"key":"10.1023\/A:1008414002612_bb0100","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1200\/JCO.1991.9.8.1426","article-title":"Similar outcome of treatment of B-cell and T-cell diffuse large-cell lymphomas: The Stanford experience","volume":"9","author":"Kwak","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008414002612_bb0105","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1182\/blood.V84.5.1359.1359","article-title":"Classification of lymphoid neoplasms","volume":"84","author":"Rosenberg","year":"1994","journal-title":"Blood"},{"key":"10.1023\/A:1008414002612_bb0110","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1097\/00001622-199210000-00007","article-title":"Prognostic factors in non-Hodgkin\u2019s lymphoma","volume":"4","author":"Shiip","year":"1992","journal-title":"Curr Opin Oncol"},{"key":"10.1023\/A:1008414002612_bb0115","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0968-6053(98)80031-8","article-title":"Classification of cutaneous lymphomas: Crosstalk between pathologist and clinician","volume":"5","author":"Willemze","year":"1998","journal-title":"Curr Diagn Pathol"},{"key":"10.1023\/A:1008414002612_bb0120","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/(SICI)1096-9896(199712)183:4<432::AID-PATH942>3.0.CO;2-4","article-title":"Cytotoxic protein expression in natural killer cell lymphomas and in alpha beta and gamma delta peripheral T-cell lymphomas","volume":"183","author":"Boulland","year":"1997","journal-title":"J Pathol"},{"key":"10.1023\/A:1008414002612_bb0125","first-page":"1893","article-title":"TIA-1 expression in lymphoid neoplasms. Identification of subsets with cytotoxic T lymphocyte or natural killer cell differentiation","volume":"150","author":"Felgar","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1023\/A:1008414002612_bb0130","series-title":"Expression of the granular lymphocyte proteins (TIA-1\/GMP-17, Perforin and Metase) in peripheral T-cell lymphomas. IX Meeting of the European Association for Haematopathology. April 26-29","author":"Krenacs","year":"1998"},{"key":"10.1023\/A:1008414002612_bb0135","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/(SICI)1097-0215(19971104)73:3<332::AID-IJC5>3.0.CO;2-0","article-title":"Nasal T\/natural killer (NK)-cell lymphomas are derived from Epstein-Barr virus infected cytotoxic lymphocytes of both NK- and T-cell lineage","volume":"73","author":"Chiang","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1023\/A:1008414002612_bb0140","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0046-8177(98)90122-8","article-title":"Subcutaneous panniculitic T-cell lymphoma is a tumor of cytotoxic T lymphocytes","volume":"29","author":"Kumar","year":"1998","journal-title":"Hum Pathol"},{"key":"10.1023\/A:1008414002612_bb0145","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1046\/j.1365-2559.1997.2660862.x","article-title":"Enteropathy-associated T-cell lymphomas have a cytotoxic T-cell phenotype","volume":"31","author":"De Bru\u00edn","year":"1997","journal-title":"Histopathology"},{"key":"10.1023\/A:1008414002612_bb0150","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1182\/blood.V88.11.4265.bloodjournal88114265","article-title":"Hepatosplenic T-cell lymphoma: A distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin","volume":"88","author":"Cooke","year":"1996","journal-title":"Blood"},{"key":"10.1023\/A:1008414002612_bb0155","first-page":"249","article-title":"Enteropathy associated T cell lymphoma","volume":"30","author":"Wr\u00edght","year":"1997","journal-title":"Cancer Surv"},{"key":"10.1023\/A:1008414002612_bb0160","first-page":"1723","article-title":"Nonhepatosplenic gammadelta T-cell lymphoma: A subset of cytotoxic lymphomas with mucosal or skin localization","volume":"91","author":"Arnulf","year":"1998","journal-title":"Blood"},{"key":"10.1023\/A:1008414002612_bb0165","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/1523-1747.ep12337633","article-title":"Most primary cutaneous CD30-positive lymphoproliferative disorders have a CD4-positive cytotoxic T-cell phenotype","volume":"109","author":"Kummer","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1023\/A:1008414002612_bb0170","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1182\/blood.V88.10.4005.bloodjournal88104005","article-title":"Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules","volume":"88","author":"Foss","year":"1996","journal-title":"Blood"},{"key":"10.1023\/A:1008414002612_bb0175","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000164108","article-title":"Uniform expression of cytotoxic molecules in anaplastic large-cell lymphoma of null\/T-cell phenotype and in cell lines derived from anaplastic large cell lymphoma","volume":"65","author":"Foss","year":"1997","journal-title":"Pathobiology"},{"key":"10.1023\/A:1008414002612_bb0180","series-title":"Cytotoxic proteins in CD30+ and CD30 negative lymphomas. IX Meeting of the European Association for Haematopathology. April 26\u201329","author":"Meijer","year":"1998"},{"key":"10.1023\/A:1008414002612_bb0185","unstructured":"Gaulard P, Personal communication."},{"key":"10.1023\/A:1008414002612_bb0190","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2141.1990.tb02560.x","article-title":"CD30-positive large-cell lymphomas (Ki-1 lymphoma) are associated with a chromosomal translocation involving 5q35","volume":"74","author":"Mason","year":"1990","journal-title":"Br J Haematol"},{"key":"10.1023\/A:1008414002612_bb0195","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1126\/science.8122112","article-title":"Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin\u2019s lymphoma","volume":"263","author":"Morris","year":"1994","journal-title":"Science"},{"key":"10.1023\/A:1008414002612_bb0200","first-page":"59","article-title":"The NPM\/ALK gene fusion in the pathogenesis of anaplastic large-cell lymphoma","volume":"30","author":"Ladany","year":"1997","journal-title":"Cancer Surv"},{"key":"10.1023\/A:1008414002612_bb0205","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1073\/pnas.93.9.4181","article-title":"Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5)","volume":"93","author":"Fujimoto","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1023\/A:1008414002612_bb0210","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/nar\/25.6.1225","article-title":"Isolation and characterization of the human nucleophosmin\/B23 (NPM) gene: Identification of the YY1 binding site at the 5\u2019 enhancer region","volume":"25","author":"Chan","year":"1996","journal-title":"Nucleid Acid Res"},{"key":"10.1023\/A:1008414002612_bb0215","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1038\/sj.onc.1201062","article-title":"ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin\u2019s lymphoma, encodes a novel neural tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK)","volume":"14","author":"Morris","year":"1997","journal-title":"Oncogene"},{"key":"10.1023\/A:1008414002612_bb0220","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/sj.onc.1200849","article-title":"Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system","volume":"14","author":"Iwahara","year":"1997","journal-title":"Oncogene"},{"key":"10.1023\/A:1008414002612_bb0225","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1128\/MCB.17.4.2312","article-title":"Role of nucleophosmin (NPM) portion of the non-Hodgkin\u2019s lymphoma-associated NPM-anaplastic kinase fusion protein in oncogenesis","volume":"17","author":"Bischof","year":"1997","journal-title":"Mol Cell Biol"},{"key":"10.1023\/A:1008414002612_bb0230","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.1182\/blood.V84.11.3648.bloodjournal84113648","article-title":"Diagnosis of t(2;5)(p23;q35)-associated Ki-1 lymphoma with immunohistochemistry","volume":"84","author":"Shiota","year":"1994","journal-title":"Blood"},{"key":"10.1023\/A:1008414002612_bb0235","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1182\/blood.V86.5.1954.bloodjournal8651954","article-title":"Anaplastic large cell lymphomas expressing the novel chimeric protein p80 NPM\/ALK: A distinct clinicopathologic entity","volume":"86","author":"Shiota","year":"1995","journal-title":"Blood"},{"key":"10.1023\/A:1008414002612_bb0240","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/annonc\/8.suppl_1.S37","article-title":"Use of an anti-ALK antibody in the characterization of anaplastic large-cell lymphoma of chilhood","volume":"8","author":"Hutchinson","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1023\/A:1008414002612_bb0245","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1182\/blood.V89.4.1394","article-title":"Detection of ALK and NPM-ALK protein in normal and neoplastic cells with the monoclonal antibody ALK1","volume":"89","author":"Pulford","year":"1997","journal-title":"Blood"},{"key":"10.1023\/A:1008414002612_bb0250","article-title":"Morphologic and phenotypic features of lymphomas expressing ALK protein","author":"Benharroch","year":"1998","journal-title":"Blood"},{"key":"10.1023\/A:1008414002612_bb0255","first-page":"1207","article-title":"Frequent expression of the p80 NPM-ALK chimeric fusion protein in anaplastic large-cell lymphoma, lympho-histiocytic type","volume":"150","author":"Pileri","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1023\/A:1008414002612_bb0260","unstructured":"Falini B, Bigerna B, Fizzotti M et al. ALK expression defines a distinct group of lymphomas (\u2018ALK lymphomas\u2019) with a wide morphologic spectrum. Am J Pathol (accepted)."},{"key":"10.1023\/A:1008414002612_bb0265","unstructured":"Haralambieva E., Pulford KAF, Lamant L et al. Anaplastic large cell lymphoma of B-cell phenotype. Cellular Sci (accepted)."},{"key":"10.1023\/A:1008414002612_bb0270","series-title":"Clinico-pathologic features of 41 cases of childhood CD30 + lymphomas: A multicentric study. IX Meeting of the European Association for Haematopathology. April 26-29","author":"Paulli","year":"1998"},{"key":"10.1023\/A:1008414002612_bb0275","series-title":"Anaplastic large-cell lymphoma Hodgkin\u2019s like (ALCL-HL): A concept reviewed. IX Meeting of the European Association for Haematopathology. April 26-29","author":"Pileri","year":"1998"},{"key":"10.1023\/A:1008414002612_bb0280","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1097\/00000478-199712000-00004","article-title":"Anaplastic large cell lymphoma: A distinct molecular pathologic entity. A reappraisal with special reference to p80 NPM\/ALK expression","volume":"21","author":"Nakamura","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"10.1023\/A:1008414002612_bb0285","author":"Falini","year":"1998"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375341955949X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375341955949X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/9\/8\/797\/19481868\/9-8-797.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,15]],"date-time":"2021-05-15T12:27:53Z","timestamp":1621081673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092375341955949X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,8]]},"references-count":56,"journal-issue":{"issue":"8","published-print":{"date-parts":[[1998,8]]}},"alternative-id":["S092375341955949X"],"URL":"https:\/\/doi.org\/10.1023\/a:1008414002612","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[1998,8]]}}}